435 related articles for article (PubMed ID: 18600597)
21. EU offers incentives to firms to produce medicines for children.
Watson R
BMJ; 2006 Jun; 332(7554):1352. PubMed ID: 16763236
[No Abstract] [Full Text] [Related]
22. "Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?
Stephenson T
Arch Dis Child; 2007 Aug; 92(8):661-3. PubMed ID: 17642477
[TBL] [Abstract][Full Text] [Related]
23. Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach.
Mandry T
Food Drug Law J; 2004; 59(4):519-35. PubMed ID: 15875348
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological research in pediatrics: From neonates to adolescents.
Rakhmanina NY; van den Anker JN
Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
[TBL] [Abstract][Full Text] [Related]
25. Pediatric cardiovascular drug development and research: integration of modeling and simulation as one future direction.
Läer S
J Cardiovasc Pharmacol; 2011 Sep; 58(3):217-27. PubMed ID: 21654330
[TBL] [Abstract][Full Text] [Related]
26. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
27. [Prescriptions and children].
Autret-Leca E; Bensouda-Grimaldi L; Le Guellec C; Jonville-Béra AP
Arch Pediatr; 2006 Feb; 13(2):181-5. PubMed ID: 16343869
[TBL] [Abstract][Full Text] [Related]
28. A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
Robinson S; Delongeas JL; Donald E; Dreher D; Festag M; Kervyn S; Lampo A; Nahas K; Nogues V; Ockert D; Quinn K; Old S; Pickersgill N; Somers K; Stark C; Stei P; Waterson L; Chapman K
Regul Toxicol Pharmacol; 2008 Apr; 50(3):345-52. PubMed ID: 18295384
[TBL] [Abstract][Full Text] [Related]
29. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
Woodward KN
J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
[TBL] [Abstract][Full Text] [Related]
30. [New guidelines of the European Union. Motivation for drug testing in pediatrics].
Appel K
Dtsch Med Wochenschr; 2001 May; 126(18):A403. PubMed ID: 11381643
[No Abstract] [Full Text] [Related]
31. Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.
Chin WW; Joos A
Eur J Pediatr; 2016 Dec; 175(12):1881-1891. PubMed ID: 27646479
[TBL] [Abstract][Full Text] [Related]
32. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].
Johannesson M; Berglund EG
Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388
[No Abstract] [Full Text] [Related]
33. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
Seyberth HW; Demotes-Mainard J; Wrobel P
Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
[No Abstract] [Full Text] [Related]
34. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
35. EU law mandates drug testing in children.
Sinha G
J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
[No Abstract] [Full Text] [Related]
36. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
37. Extra-label drug use--pharmaceutical industry view.
Welser JR
J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
[No Abstract] [Full Text] [Related]
38. The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.
Läer S; Barrett JS; Meibohm B
J Clin Pharmacol; 2009 Aug; 49(8):889-904. PubMed ID: 19531673
[TBL] [Abstract][Full Text] [Related]
39. Unlicensed and off-label drug use in children.
Bavdekar SB; Gogtay NJ
J Postgrad Med; 2005; 51(4):249-52. PubMed ID: 16388164
[No Abstract] [Full Text] [Related]
40. The use of unlicensed and off-label medicines in the neonate.
Conroy S; McIntyre J
Semin Fetal Neonatal Med; 2005 Apr; 10(2):115-22. PubMed ID: 15701577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
